Masonic Cancer Center, University of Minnesota

What's Inside

Quick Links for:

Cancer Information Line
Ask about cancer, clinical trials, and how to make an appointment:
cancerinfo@umn.edu
612-624-2620

Toll-free in IA, MN, ND, SD, WI: 1-888-CANCER MN
(1-888-226-2376)

A Comprehensive Cancer Center Designated by the National Cancer Institute
Print this page. Mail this link to a friend.

Kenneth S. Koeneman, M.D.

koeneman

Research Program: Tumor Biology and Progression
Associate Professor, Department of Urologic Surgery
Director, Center for Prostate Cancer
Dougherty Family Chair in Uro-Oncology

koene026@umn.edu
612-626-0964 — office
612-625-7442 — lab
Preferred contact method: office phone

Dr. Koeneman's clinical profile
(University of Minnesota Physicians Web site)

Dr. Koenemann received his M.D. in 1992 from the University of Illinois at Chicago. He conducted general surgery and urologic surgery residencies at Loyola University Medical Center from 1994-1998, and was a urologic oncology research fellow at the University of Virginia in Charlottesville from 1998-2000. He was a clinical assistant professor in the Department of Urology the University of Virginia until the year 2000, when he joined the Department of Urologic Oncology at the University of Texas Soutohwestern Medical School in Dallas as an assistant professor. He came to the Department of Urologic Surgery at the University of Minnesota at in 2004, where he is currently an associate professor and holds the Dougherty Family Chair in Uro-Oncology. Dr. Koeneman also directs the Center for Prostate Cancer

Research Interests

Prostate cancer bone metastasis, markers, and novel treatment paradigms.

Selected Publications

Karam JA, Mason RP, Koeneman KS, Antich PP, Benaim EA, Hsieh JT. Molecular imaging in prostate cancer. J Cell Biochem. 2003;90:473-483.

Shariatt, S., Khoddami, S., Saborian, H., Koeneman, K., Sagalowsky, A., Cadeddu, J., McConnell, J., Holmes, M., Roehrborn, C. Lympho-vascular invasion as a pathologic geature in biologically aggressive disease in patients treated with radical prostatectomy. J Urol. 2004; 171:1122-1127.

Lotan, Y., Shariat, S., Khoddami, S., Koeneman, K., Cadeddu, J., Sagalowsky, A., McConnell, J., Roehrborn, C.: The percent of biopsy cores positive for cancer is a predictor of advanced pathologic stage and poor clinical outcomes in patients treated with radical prostatectomy. J Urol. 2004;171:2209-2214.

Khoddami, S., Shariat, S., Lotan, Y., Saboorian, H., McConnell, Sagalowsky, A., Roehrborn, C., Koeneman, K.S.: Predictive value of primary Gleason pattern 4 in Gleason score 7 patients treated with radical prostatectomy. Br J Urol. 2004;94:42-46.